Additionally, the FFAR2 specific allosteric agonist CFMB had decreasing effects on TNF-α-induced MCP-1 upregulation in cortical epithelial cells, indicating an anti-inflammatory effect of FFA2 and FFA3 receptor signaling in renal diseases [124]. The gene discussed is FFAR2; the disease is kidney disorder.